For people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher likelihood of an excellent recovery and reduced disability three months later than the drug alteplase, according to a meta-analysis published in the October 16, 2024, online issue of Neurology. Researchers found that the likelihood of good recovery was similar between the two treatments.
Medical Xpress – latest medical and health news stories
